Illumina Buys Epicentre Biotechnologies, Launches MiSeq Platform
January 12, 2011
Illumina Buys Epicentre Biotechnologies, Launches MiSeq Platform
The firm also plans to introduce upgrades for both its HiSeq 2000 and HiSeq 1000 platforms in the spring and expects reagent costs to drop to around $5,000 per genome.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Illumina Acquires Moleculo, Pre-announces Q4 Revenue Growth of 8 Percent
January 8, 2013 / GenomeWeb Daily News - New Products: Illumina's BaseSpace; GE Healthcare's GenomiPhi; Epicentre's ScriptSeq Complete Kits
July 24, 2012 / In Sequence - New Illumina Kits will Streamline Workflow, Lower DNA Input, Increase Multiplexing
July 3, 2012 / In Sequence - Product Watch: Fluidigm, Agilent, Bioline, Boreal Genomics
February 16, 2012 / PCR Insider - Sandia Labs Developing Automated Sample Prep for Sequencing of Unknown Pathogens
May 12, 2011 / PCR Insider